Doxy PEP Does Not Lower Risk of STIs in Cisgender Women

Postexposure prophylaxis with doxycycline has been shown to significantly reduce the risk of STIs in men and transgender women. Now a study looks at its efficacy in cisgender women taking HIV PrEP.
Medscape Medical News